{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:27:29Z","timestamp":1788798449831,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":92,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Catholic University of the Sacred Heart","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008908","name":"Universit\u00e0 degli Studi di Messina","doi-asserted-by":"publisher","award":["25-24\/2024"],"award-info":[{"award-number":["25-24\/2024"]}],"id":[{"id":"10.13039\/501100008908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.labinv.2025.104120","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:16:17Z","timestamp":1740395777000},"page":"104120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Roles for Androgen Receptor, ADAR2, and PD-L1 in Primary Urothelial Carcinoma In Situ of the Bladder Treated with Bacillus Calmette\u2013Gu\u00e9rin Therapy"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1349-0910","authenticated-orcid":false,"given":"Gabriele","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-1761","authenticated-orcid":false,"given":"Vincenzo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pierconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Giuseppe","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1905-8700","authenticated-orcid":false,"given":"Emanuela","family":"German\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Racioppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rossanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-7174","authenticated-orcid":false,"given":"Cristina","family":"Pizzimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tuccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-1807","authenticated-orcid":false,"given":"Angela","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-1796","authenticated-orcid":false,"given":"Valeriana","family":"Cesarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-6310","authenticated-orcid":false,"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2025.104120_bib1","series-title":"Urinary and Male Genital Tumours, WHO Classification of Tumours","first-page":"147","article-title":"Urothelial carcinoma in situ","author":"Williamson","year":"2022"},{"key":"10.1016\/j.labinv.2025.104120_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.euf.2019.03.012","article-title":"Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes","volume":"6","author":"Subiela","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.labinv.2025.104120_bib3","first-page":"1069","article-title":"Carcinoma in situ of the urinary bladder \u2013 from pathology to narrow band imaging","volume":"56","author":"Geavlete","year":"2015","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.labinv.2025.104120_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00428-013-1378-4","article-title":"Different subtypes of carcinoma in situ of the bladder do not have a different prognosis","volume":"462","author":"Comp\u00e9rat","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.labinv.2025.104120_bib5","first-page":"1021","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.labinv.2025.104120_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.labinv.2025.104120_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1756287215599694","article-title":"Management of carcinoma in situ of the bladder: best practice and recent developments","volume":"7","author":"Tang","year":"2015","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.labinv.2025.104120_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MOU.0000000000000595","article-title":"Bacillus Calmette\u2013Gu\u00e9rin treatment of bladder cancer: a systematic review and commentary on recent publications","volume":"29","author":"Mukherjee","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.labinv.2025.104120_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers9020020","article-title":"Androgen receptor signaling in bladder cancer","volume":"9","author":"Li","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2025.104120_bib10","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1530\/ERC-15-0209","article-title":"The emerging role of the androgen receptor in bladder cancer","volume":"22","author":"Lombard","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.labinv.2025.104120_bib11","doi-asserted-by":"crossref","first-page":"49169","DOI":"10.18632\/oncotarget.9994","article-title":"Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer","volume":"7","author":"Kashiwagi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.labinv.2025.104120_bib12","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1158\/1535-7163.MCT-14-1055-T","article-title":"Antiandrogen therapy with hydroxyflutamide or androgen receptor degradation enhancer ASC-J9 enhances BCG efficacy to better suppress bladder cancer progression","volume":"14","author":"Shang","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.labinv.2025.104120_bib13","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41417-022-00506-w","article-title":"Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2\/circ_0001005\/PD-L1 signaling","volume":"29","author":"Liu","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.labinv.2025.104120_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1481296","article-title":"Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.labinv.2025.104120_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2017.11.018","article-title":"ADARs and editing: the role of A-to-I RNA modification in cancer progression","volume":"79","author":"Fritzell","year":"2018","journal-title":"Semin Cell Develop Biol"},{"key":"10.1016\/j.labinv.2025.104120_bib16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/cancers16040746","article-title":"Roles of androgen receptor signaling in urothelial carcinoma","volume":"16","author":"Sundi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2025.104120_bib17","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9537","article-title":"Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette\u2013Gu\u00e9rin therapy in bladder cancer","volume":"7","author":"Pichler","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.labinv.2025.104120_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41416-022-02046-4","article-title":"REMARK guidelines for tumour ebiomarker study reporting: a remarkable history","volume":"128","author":"Hayes","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.labinv.2025.104120_bib19","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cncr.27821","article-title":"Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis","volume":"119","author":"Martini","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2025.104120_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00262-021-02960-1","article-title":"Predictive value of NLR, TILs (CD4+\/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer","volume":"71","author":"Zurlo","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.labinv.2025.104120_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00345-020-03358-x","article-title":"Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival","volume":"39","author":"Toren","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.labinv.2025.104120_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","article-title":"ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism","volume":"22","author":"Tassinari","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.labinv.2025.104120_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/biom12081142","article-title":"ADAR2 protein is associated with overall survival in GBM patients and its decrease triggers the anchorage-independent cell growth signature","volume":"12","author":"Cesarini","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.labinv.2025.104120_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/his.14562","article-title":"Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study","volume":"80","author":"Cerbelli","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.labinv.2025.104120_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12020-016-0866-0","article-title":"The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms","volume":"54","author":"Rossi","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.labinv.2025.104120_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00428-020-02755-2","article-title":"PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders","volume":"477","author":"Pierconti","year":"2020","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.labinv.2025.104120_bib27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00262-006-0266-z","article-title":"Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers","volume":"56","author":"Nakanishi","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.labinv.2025.104120_bib28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cncr.22588","article-title":"PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomatar: associations with localized stage progression","volume":"109","author":"Inman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2025.104120_bib29","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3390\/ijms18102186","article-title":"Regulatory T cells and tumor-associated macrophages in the tumor microenvironment in non-muscle invasive bladder cancer treated with intravesical Bacille Calmette-Gu\u00e9rin: a long-term follow-up study of a Japanese cohort","volume":"18","author":"Miyake","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2025.104120_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/bju.15276","article-title":"Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"127","author":"Kardoust Parizi","year":"2021","journal-title":"BJU International"},{"key":"10.1016\/j.labinv.2025.104120_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2019.12.014","article-title":"Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217\/miRNA-646\/TGF\u03b21\/p-Smad2\/3 signaling","volume":"472","author":"Xu","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.labinv.2025.104120_bib32","doi-asserted-by":"crossref","first-page":"D925","DOI":"10.1093\/nar\/gkx863","article-title":"CSCD: a database for cancer-specific circular RNAs","volume":"46","author":"Xia","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.labinv.2025.104120_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948467","article-title":"Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion","volume":"21","author":"Chen","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.labinv.2025.104120_bib34","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2025.104120_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1615\/CritRevImmunol.2016017387","article-title":"Metabolic regulation of natural killer cell IFN-\u03b3 production","volume":"36","author":"Mah","year":"2016","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.labinv.2025.104120_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cancers14020263","article-title":"IFN-gamma expression in the tumor microenvironment and CD8-positive tumor-infiltrating lymphocytes as prognostic markers in urothelial cancer patients receiving pembrolizumab","volume":"14","author":"Sakatani","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2025.104120_bib37","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/ijms22062800","article-title":"Improving anti-PD-1\/PD-L1 therapy for localized bladder cancer","volume":"22","author":"de Jong","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2025.104120_bib38","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","article-title":"Bladder cancer organoids as a functional system to model different disease stages and therapy response","volume":"14","author":"Minoli","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2025.104120_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95157-6","article-title":"MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model","volume":"11","author":"de Queiroz","year":"2021","journal-title":"Sci Rep"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:00:17Z","timestamp":1762210817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0023683725000303"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104120","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles for Androgen Receptor, ADAR2, and PD-L1 in Primary Urothelial Carcinoma In Situ of the Bladder Treated with Bacillus Calmette\u2013Gu\u00e9rin Therapy","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"104120"}}